DiaSorin DiaSorin Q1 Revenues Rise 53 Percent on SARS-CoV-2 Testing Demand The company said that its Q1 revenue growth was driven in part by SARS-CoV-2 test revenues of €102.0 million, booked mainly in the US, Canada, and Europe. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence Premium DiaSorin said that the acquisition gives it access to Luminex's multiplexing technology, tests, and instruments and strengthens its MDx product portfolio. DiaSorin to Acquire Luminex for $1.8B DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years. Luminex Shares Surge on Rumor of Acquisition by DiaSorin Investors responded to a report on Thursday that DiaSorin is considering the purchase of Luminex, one of its in vitro diagnostic testing competitors. BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests The funding will be used to validate the Simplexa COVID-19 Direct kit and Simplexa COVID-19 & Flu A/B Direct kit and to submit them to the FDA for 510(k) clearance. Sep 17, 2020 DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test Sep 8, 2020 FDA Clears DiaSorin Test for Influenza, RSV Jul 7, 2020 DiaSorin Molecular Gets CE Mark for Flu, RSV Assay Jun 15, 2020 DiaSorin Molecular Gets CE Mark for Congenital CMV Assay Apr 13, 2020 Coronavirus Tests From Seegene, DiaSorin, Others Get Health Canada Approval Mar 20, 2020 Coronavirus Test From DiaSorin Molecular Gets FDA Emergency Use Authorization Mar 13, 2020 DiaSorin Molecular Awarded $679K BARDA Funding to Develop Coronavirus Test Mar 2, 2020 TTP Licenses Sample-to-Answer Dx System to DiaSorin Dec 17, 2019 FDA Clears DiaSorin Molecular VZV Test Sep 25, 2019 DiaSorin Molecular Gets CE Mark for VZV Swab Direct Molecular Test May 30, 2019 FDA Clears DiaSorin Molecular Meningitis, Encephalitis Assay May 16, 2019 DiaSorin Molecular Gets CE Mark for Herpes Virus Assay Jan 8, 2019 DiaSorin Whooping Cough Test Clears FDA With Additional Claim Nov 26, 2018 Group B Strep Test From DiaSorin Molecular Cleared by FDA Oct 18, 2018 DiaSorin Receives CE Mark for Simplexa Group B Strep Assay Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.